Clinical Trial Update: Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of the vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetics with coro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin/metformin (vildagliptin/metformin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Type 2 Diabetes Mellitus, Ischemic Heart Disease | Phase 4 | Status: COMPLETED